FDA.reportPublic FDA data

SYMFI 600 MG / 300 MG / 300 MG Oral Tablet

RxCUI
2043464
RxNorm name
SYMFI 600 MG / 300 MG / 300 MG Oral Tablet
Display name
SYMFI 600 MG / 300 MG / 300 MG Oral Tablet
Full name
SYMFI 600 MG / 300 MG / 300 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SYMFIEFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATEViatris Specialty LLC81a55dd9-78a8-49c3-88ab-8f5bffafa3592019-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2043464

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
81a55dd9-78a8-49c3-88ab-8f5bffafa359SYMFI 600 MG / 300 MG / 300 MG Oral Tablet [PSN] · efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi] [SBD] · efavirenz 600 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi] [SY] · Symfi (efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet [SY]46These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 201820191015